Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.8.0.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenues    
Product revenue, net $ 4,260,119 $ 0
Sales force revenue 222,656 0
Grant revenue 0 384,206
Total revenues, net 4,482,775 384,206
Operating expenses:    
Cost of product sales 863,624 0
Research and development 1,649,778 953,071
General and administrative 2,918,916 1,330,264
Sales and marketing 1,524,816 0
Amortization expense 1,017,408 0
Total operating expenses 7,974,542 2,283,335
Loss from operations (3,491,767) (1,899,129)
Other (expense) income:    
Change in fair value of contingent consideration, warrant liability and unit purchase option liability (286,020) (3,761)
Other income 18,655 0
Interest expense, net (100,402) (57,748)
Total other expense, net (367,767) (61,509)
Net loss before taxes (3,859,534) (1,960,638)
Income tax expense 23,313 0
Net loss $ (3,882,847) $ (1,960,638)
Net loss per share of common stock, basic and diluted (in dollars per share) $ (0.12) $ (0.19)
Weighted average shares of common stock outstanding, basic and diluted (in shares) 31,316,246 10,216,014